APA

Liu Y., Huang J., Guo C., Yang S., Ye L., Wu S., Zhang X., Yang X., Han C., Pei Q., Huang L., He Q. & Yang G. (20201112). A randomized, double-blind, single-dose study to evaluate the biosimilarity of QL1101 with bevacizumab in healthy male subjects. : Cancer chemotherapy and pharmacology.

Chicago

Liu Ya-Nan, Huang Jie, Guo Can, Yang Shuang, Ye Ling, Wu Shu-Ting, Zhang Xing-Fei, Yang Xiao-Yan, Han Cui-Cui, Pei Qi, Huang Lu, He Qing-Nan and Yang Guo-Ping. 20201112. A randomized, double-blind, single-dose study to evaluate the biosimilarity of QL1101 with bevacizumab in healthy male subjects. : Cancer chemotherapy and pharmacology.

Harvard

Liu Y., Huang J., Guo C., Yang S., Ye L., Wu S., Zhang X., Yang X., Han C., Pei Q., Huang L., He Q. and Yang G. (20201112). A randomized, double-blind, single-dose study to evaluate the biosimilarity of QL1101 with bevacizumab in healthy male subjects. : Cancer chemotherapy and pharmacology.

MLA

Liu Ya-Nan, Huang Jie, Guo Can, Yang Shuang, Ye Ling, Wu Shu-Ting, Zhang Xing-Fei, Yang Xiao-Yan, Han Cui-Cui, Pei Qi, Huang Lu, He Qing-Nan and Yang Guo-Ping. A randomized, double-blind, single-dose study to evaluate the biosimilarity of QL1101 with bevacizumab in healthy male subjects. : Cancer chemotherapy and pharmacology. 20201112.